The selection and use of essential medicines.
Material type: TextPublication details: Italy : WHO, 2015. Description: 545 p. : ill. ; 23 cmISBN: 9789241209946Subject(s): DrugNLM classification: QV 55 S 2015Summary: This report presents the recommendations of the WHO Expert Committee responsible for updating the WHO Model Lists of Essential Medicines.. The goal of the meeting was to review and update the 18th WHO Model List of Essential Medicines (EML) and the 4th WHO Model List of Essential Medicines for Children (EMLc). In accordance with approved procedures, the Expert Committee evaluated the scientific evidence on the basis of the comparative effectiveness, safety and cost effectiveness of the medicines. Both lists went through major revisions this year, as the Committee considered 77 applications, including 29 treatment regimens for cancer, and innovative hepatitis C and tuberculosis (TB) medicines. The Expert Committee recommended the addition of 36 new medicines to the EML (15 to the core list and 21 to the complementary list); and recommended the addition of 16 new medicines to the EMLc (five to the core list and 11 to the complementary list). Annexes to the main report include the revised version of the WHO Model List of Essential Medicines (19th edition) and the WHO Model List of Essential Medicines for Children (5th edition). In addition there is a list of all the items on the Model List sorted according to their Anatomical Therapeutic Chemical (ATC) classification codes.Item type | Current library | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|
WHO Publications | FNPH LIBRARY | QV 55 S 2015 (Browse shelf(Opens below)) | Available | FNPH-LIB 10545 |
Browsing FNPH LIBRARY shelves Close shelf browser (Hides shelf browser)
No cover image available | No cover image available | |||||||
QV 55 PM 1999 The complete drug reference. | QV 55 S 2012 The selection and use of essential medicines : | QV 55 S 2014 The selection and use of essential medicines. | QV 55 S 2015 The selection and use of essential medicines. | QV 55 TD 2001 The medical letter on drugs and therapeutics : | QV 55 W 2016 WHO drug information. | QV 55 W 2016 WHO drug information. |
This report presents the recommendations of the WHO Expert Committee responsible for updating the WHO Model Lists of Essential Medicines.. The goal of the meeting was to review and update the 18th WHO Model List of Essential Medicines (EML) and the 4th WHO Model List of Essential Medicines for Children (EMLc).
In accordance with approved procedures, the Expert Committee evaluated the scientific evidence on the basis of the comparative effectiveness, safety and cost effectiveness of the medicines. Both lists went through major revisions this year, as the Committee considered 77 applications, including 29 treatment regimens for cancer, and innovative hepatitis C and tuberculosis (TB) medicines. The Expert Committee recommended the addition of 36 new medicines to the EML (15 to the core list and 21 to the complementary list); and recommended the addition of 16 new medicines to the EMLc (five to the core list and 11 to the complementary list).
Annexes to the main report include the revised version of the WHO Model List of Essential Medicines (19th edition) and the WHO Model List of Essential Medicines for Children (5th edition). In addition there is a list of all the items on the Model List sorted according to their Anatomical Therapeutic Chemical (ATC) classification codes.
There are no comments on this title.